Search results

ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.

The release of the Oppenheimer film, the story of the director of the Manhattan Project,  has prompted many people to go online and search for an explanation of the difference between fission and fusion, two fundamental scientific concepts.

Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.

NSW grants bolster additive manufacturing and groundwater processing capabilities.

Today Dr Jenine McCutcheon from the University of Queensland’s School of Earth and Environmental Sciences has been recognised for her outstanding research with the Australian Synchrotron's Stephen Wilkins Medal.

This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors safe and minimise the risk of the spread of COVID-19 infection.

Three new federal grants were announced to support manufacturing and nuclear technologies.

The Scientific Computing team supports researchers by performing numerical simulations that complement experimental research. In particular, we use state-of-the-art software to perform computational quantum mechanical modelling, molecular dynamics simulations, lattice dynamics calculation, data analysis and visualisations.

A large international research team led by Academia Sinica in Taiwan investigated how heat is transferred in an advanced thermoelectric material made with germanium (Ge) and tellurium (Te) and doped with antimony (Sb). These devices are used to power space probes such as the Mars Curiosity Rover.

With world-class experts in groundwater and major contributions in this area over two decades, ANSTO completed a major project report on Improving groundwater sustainability and renewability using isotope hydrochemistry in NSW for the Department of Planning and Environment (NSW) and National Water Grid earlier in the year.

Australia’s nuclear agency ANSTO is continuing to lead planning efforts to repatriate what is called a TN-81 cask of intermediate-level radioactive from the United Kingdom in 2022.

To enable the production of nuclear medicine, ANSTO operates manufacturing, processing and distribution facilities in Sydney.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.